Delivery Order SPE2DB22D2007-SPE2DB25FJ4ZU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,261.13 to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.625 mg on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $4,934.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.3 mg on April 21, 2025, with an ultimate completion date of April 22, 2025. This non-set-aside contract represents a single delivery order executed under AmerisourceBergen's broader pharmaceutical supply framework with the federal government. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a competitive delivery order valued at $1,219.47 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count units). This firm fixed-price delivery order, issued on July 14, 2025, with an ultimate completion date of July 15, 2025, represents a continuation of AmerisourceBergen's pharmaceutical supply support to the federal government. The award was made without any set-aside designation, indicating it was competitively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Premarin 0.625 mg tablets in quantities of 100, with a contract ceiling value of $3,141.71. This is a firm fixed price delivery order with an ultimate completion date of August 14, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Premarin 0.3 mg tablets (100 count) with a contract value of $1,695.84 and a firm fixed price structure. The delivery order, which is set to be completed by June 23, 2025, will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a non-competitive delivery order issued under a larger contract vehicle,...
- The Defense Logistics Agency awarded a delivery order valued at $2,234.15 to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.9 mg on August 21, 2025, with completion scheduled for August 22, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a purchase of a hormone replacement therapy medication supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Premarin 0.3 mg tablets (100-count units) under a firm fixed-price contract valued at $1,208.97. The award, issued on May 12, 2025, with an ultimate completion date of May 13, 2025, represents a non-set-aside competitive procurement. Performance will occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,385.11 to AmerisourceBergen Drug Corp for 1,000 tablets of Premarin 0.3 mg, a hormone replacement therapy medication. This non-set-aside contract was competitively awarded with a firm fixed price structure and an ultimate completion date of August 4, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,654.18 to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.625 mg, a hormone replacement therapy medication. The contract is a firm fixed price delivery order with an ultimate completion date of August 12, 2025, and carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Premarin 0.3 mg tablets (100 count) on August 14, 2025, with an ultimate completion date of August 15, 2025. Valued at $1,512.09 under a firm fixed-price arrangement, this non-competitive delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements. The contract is fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken,...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4ZUDelivery Order
The Defense Logistics Agency awarded a $1,674.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.45 mg on September 16, 2025, with completion expected by September 17, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The award carries no set-aside designation, indicating competitive procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a prime vendor under the DLA Troop Support Medical global pharmaceutical support vehicle, AmerisourceBergen supplies a comprehensive range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. This delivery order for Premarin, a hormone replacement therapy medication, exemplifies the company's role in fulfilling federal medical procurement needs across multiple therapeutic domains for the Defense Health Agency and other government healthcare systems. The non-set-aside competitive award reflects AmerisourceBergen's demonstrated capability to meet federal pharmaceutical supply requirements on an open market basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/16/25 |